Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Ardelyx, Inc. (NASDAQ: ARDX).

Full DD Report for ARDX

You must become a subscriber to view this report.


Recent News from (NASDAQ: ARDX)

Ardelyx Looks Cheap But Not Without Risk
This article was co-authored by Stepan Lavrouk, an investment analyst with Almington Capital. Ardelyx ( ARDX ) is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of small-molecule treatments for gastrointestinal (“GI ...
Source: SeekingAlpha
Date: May, 17 2018 02:19
Ardelyx beats by $0.10
Ardelyx (NASDAQ: ARDX ): Q1 EPS of -$0.36 beats by $0.10 . More news on: Ardelyx, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 08 2018 17:13
Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights
FREMONT, Calif. , May 8, 2018 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), today reported business highlights and financial results for the first quarter ended March 31, 2018 . "The first quarter of 2018 has been about execution for Ardelyx," said Mike Raab , president and ch...
Source: PR Newswire
Date: May, 08 2018 16:05
Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics - Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, April 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Euronet Worldwide, Inc. (NASDAQ:EEFT), Innospec Inc. (NASDAQ:IOSP), Zosa...
Source: GlobeNewswire
Date: April, 05 2018 08:15
Biotech Forum Daily Digest For March 19th
"There are two ways to be fooled. One is to believe what isn't true; the other is to refuse to believe what is true." - Søren Kierkegaard After a big surge last week, the markets largely spent this week drifting down and giving back a portion of the previous week's rally. For the week...
Source: SeekingAlpha
Date: March, 19 2018 11:42
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada
FREMONT, Calif. , March 19, 2018 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX) today announced a license agreement with Knight Therapeutics, Inc. (TSX: GUD) (Knight) that provides Knight with exclusive rights to commercialize tenapanor in Canada . Tenapanor is Ardelyx's oral, first-i...
Source: PR Newswire
Date: March, 19 2018 06:30
Ardelyx EPS of $0.21
Ardelyx (NASDAQ: ARDX ): Q4 EPS of $0.21 may not be comparable to consensus of -$0.41. Revenue of $0.04M Press Release More news on: Ardelyx, Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: March, 14 2018 16:26
Ardelyx Reports 2017 Financial Results and Appoints Industry Veteran, Jan Lundberg, Ph.D., to Board of Directors
FREMONT, Calif. , March 14, 2018 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), today reported pipeline highlights and financial results for the fourth quarter and full-year ended December 31, 2017 . In addition, industry-leading research expert, Jan M. Lundberg , Ph.D., has been appoint...
Source: PR Newswire
Date: March, 14 2018 16:05
Consolidated Research: 2018 Summary Expectations for Progress Software, Cracker Barrel Old Country Store, Natural Grocers by Vitamin Cottage, VBI Vaccines, Ardelyx, and CytomX Therapeutics - Fundamental Analysis, Key Performance Indications
NEW YORK, Feb. 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Progress Software Corporation (NASDAQ:PRGS), Cracker Barrel Old Country S...
Source: GlobeNewswire
Date: February, 26 2018 08:20
Ardelyx (ARDX) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow
The following slide deck was published by Ardelyx in conjunction with this Read more ...
Source: SeekingAlpha
Date: February, 16 2018 13:19

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-185.705.755.805.65103,895
2018-05-175.705.755.805.65103,895
2017-06-204.704.654.854.55423,403
2017-06-194.354.654.704.30375,824
2017-06-164.404.354.45134.20667,078

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1743,26182,04152.7310Short
2018-08-1663,75787,45672.9018Short
2018-08-1527,01044,35760.8923Short
2018-08-147,70740,09719.2209Cover
2018-08-1349,73189,43955.6033Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ARDX.


About Ardelyx, Inc. (NASDAQ: ARDX)

Logo for Ardelyx, Inc. (NASDAQ: ARDX)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $246,348,464 - 05/11/2018
  • Issue and Outstanding: 47,603,568 - 03/08/2018

 


Recent Filings from (NASDAQ: ARDX)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 26 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 26 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 24 2018
Annual statement of changes in beneficial ownership of securities
Filing Type: 5Filing Source: edgar
Filing Date: April, 13 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: March, 16 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: ARDX)

Daily Technical Chart for (NASDAQ: ARDX)


Stay tuned for daily updates and more on (NASDAQ: ARDX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ARDX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ARDX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ARDX and does not buy, sell, or trade any shares of ARDX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/